Causes and risk factors for death in systemic sclerosis: A study from the EULAR Scleroderma Trials and Research (EUSTAR) database

Annals of the Rheumatic Diseases

Volumn 69, Issue 10, 2010, Pages 1809-1815

  Tyndall, Anthony J ^a   Bannert, Bettina ^a   Vonk, Madelon ^b   Airò, Paolo ^c   Cozzi, Franco ^d   Carreira, Patricia E ^e   Bancel, Dominique Farge ^f   Allanore, Yannick ^g   Müller Ladner, Ulf ^h   Distler, Oliver ⁱ   Iannone, Florenzo ^j   Pellerito, Raffaele ^k   Pileckyte, Margarita ^l   Miniati, Irene ^m   Ananieva, Lidia ⁿ   Gurman, Alexandra Balbir ^o   Damjanov, Nemanja ^p   Mueller, Adelheid ^q   Valentini, Gabriele ^r   Riemekasten, Gabriela ^s   Tikly, Mohammed ^t   Hummers, Laura ^u   Henriques, Maria J S ^v   Caramaschi, Paola ^w   Scheja, Agneta ^x   Rozman, Blaz ^y   Ton, Evelien ^z   Kumánovics, Gábor ^aa   Coleiro, Bernard ^ab   Feierl, Eva ^ac   Szucs, Gabriella ^ad   Von Mühlen, Carlos Alberto ^ae   Riccieri, Valeria ^af   Novak, Srdan ^ag   Chizzolini, Carlo ^ah   Kotulska, Anna ^ai   Denton, Christopher ^aj   Coelho, Paulo C ^ak   Kötter, Ina ^al   Simsek, Ismail ^am   Lefebvre, Paloma García De La Pena ^an   Hachulla, Eric ^ao   Seibold, James R ^ap   Rednic, Simona ^aq   Štork, Jiří ^ar   Morovic Vergles, Jadranka ^as   Walker, Ulrich A ^a   more..

^a UNIVERSITY OF BASEL   (Switzerland)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Servizio di Immunologia Clinica e Allergologia   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^f SAINT LOUIS HOSPITAL   (France)

^g Department of Rheumatology Hopital Cochin ^*  (France)

^h KERCKHOFF HEART CENTER   (Germany)

ⁱ UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^j UNIVERSITY OF BARI   (Italy)

^k MAURIZIANO HOSPITAL   (Italy)

^l KAUNAS UNIVERSITY OF MEDICINE HOSPITAL   (Lithuania)

^m UNIVERSITY OF FLORENCE   (Italy)

ⁿ V A NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY   (Russian Federation)

^o B Shine Department of Rheumatology   (Israel)

^p INSTITUTE OF RHEUMATOLOGY   (Serbia)

^q UNIVERSITY OF REGENSBURG   (Germany)

^r Dipartimento Medicina Clinica e Sperimentale 'F Magrassi' Il Policlinico UO Reumatologia   (Italy)

^s CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^t UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^u JOHNS HOPKINS UNIVERSITY   (United States)

^v CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^w UNIVERSITY OF VERONA   (Italy)

^x LUND UNIVERSITY HOSPITAL   (Sweden)

^y UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^z UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^aa UNIVERSITY OF PÉCS   (Hungary)

^ab 'Stella Maris' Balzan ^*  (Malta)

^ac MEDICAL UNIVERSITY OF VIENNA   (Austria)

^ad UNIVERSITY OF DEBRECEN   (Hungary)

^ae Rheuma Clinic   (Brazil)

^af SAPIENZA UNIVERSITY OF ROME   (Italy)

^ag KBC RIJEKA   (Croatia)

^ah UNIVERSITY HOSPITAL   (Switzerland)

^ai MEDICAL UNIVERSITY OF SILESIA   (Poland)

^aj ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^ak INSTITUTO PORTUGUÊS DE REUMATOLOGIA   (Portugal)

^al UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^am GULHANE SCHOOL OF MEDICINE   (Turkey)

^an HOSPITAL RAMÓN Y CAJAL   (Spain)

^ao LILLE UNIVERSITY HOSPITAL   (France)

^ap UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^aq IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^ar CHARLES UNIVERSITY   (Czech Republic)

^as University of Zagreb School of Medicine   (Croatia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COMORBIDITY; DATA BASE; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; INFECTION; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QUESTIONNAIRE; RISK FACTOR; SYSTEMIC SCLEROSIS; AGED; CLINICAL TRIAL; EPIDEMIOLOGY; GASTROINTESTINAL HEMORRHAGE; HEART DISEASE; LUNG DISEASE; MIDDLE AGED; MULTICENTER STUDY; NEOPLASM; PNEUMONIA; PROGNOSIS; SEPSIS;

ADULT; AGED; COMORBIDITY; EPIDEMIOLOGIC METHODS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART DISEASES; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; NEOPLASMS; PNEUMONIA; PROGNOSIS; SCLERODERMA, SYSTEMIC; SEPSIS;

EID: 77957286169     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2009.114264     Document Type: Article

References (29)

1. Bryan C, Knight C, Black CM, et al. Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit. Arthritis Rheum 1999;42:2660-5.
2. Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, et al. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 2005;118:2-10.
3. Jacobsen S, Halberg P, Ullman S. Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol 1998;37:750-5. (Pubitemid 128460491)
4. Chung L, Krishnan E, Chakravarty EF. Hospitalizations and mortality in systemic sclerosis: results from the Nationwide Inpatient Sample. Rheumatology (Oxford) 2007;46:1808-13.
5. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007;66:940-4.
6. Walker UA, Tyndall A, Czirják L, et al. Geographical variation of disease manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research (EUSTAR) group database. Ann Rheum Dis 2009;68:856-62.
7. Walker UA, Tyndall A, Czirják L, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis 2007;66:754-63.
8. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
9. Hachulla E, Carpentier P, Gressin V, et al. Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinérAIR-Sclérodermie study. Rheumatology (Oxford) 2009;48:304-8.
10. Allanore Y, Meune C, Vonk MC, et al. Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database patients with systemic sclerosis. Ann Rheum Dis 2010;69:218-21.
11. Steen VD, Medsger TA Jr. Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum 1998;41:1613-19.
12. Daniels CE, Yi ES, Ryu JH. Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis. Eur Respir J 2008;32:170-4.
13. Highland KB, Garin MC, Brown KK. The spectrum of scleroderma lung disease. Semin Respir Crit Care Med 2007;28:418-29.
14. Hill CL, Nguyen AM, Roder D, et al. Risk of cancer in patients with scleroderma: a population based cohort study. Ann Rheum Dis 2003;62:728-31.
15. Chatterjee S, Dombi GW, Severson RK, et al. Risk of malignancy in scleroderma: a population-based cohort study. Arthritis Rheum 2005;52:2415-24. (Pubitemid 41117427)
16. Shoenfeld Y, Gerli R, Doria A, et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 2005;112:3337-47.
17. Hahn BH, Grossman J, Chen W, et al. The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia. J Autoimmun 2007;28:69-75.
18. Akram MR, Handler CE, Williams M, et al. Angiographically proven coronary artery disease in scleroderma. Rheumatology (Oxford) 2006;45:1395-8.
19. Hettema ME, Zhang D, de Leeuw K, et al. Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factors. Arthritis Res Ther 2008;10:R49.
20. Follansbee WP, Miller TR, Curtiss EI, et al. A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma). J Rheumatol 1990;17:656-62.
21. Sears MR, Rea HH, de Boer G, et al. Accuracy of certification of deaths due to asthma. A national study. Am J Epidemiol 1986;124:1004-11.
22. Lloyd-Jones DM, Martin DO, Larson MG, et al. Accuracy of death certificates for coding coronary heart disease as the cause of death. Ann Intern Med 1998;129:1020-6.
23. Hirst C, Swingler R, Compston DA, et al. Survival and cause of death in multiple sclerosis: a prospective population-based study. J Neurol Neurosurg Psychiatr 2008;79:1016-21.
24. Czirják L, Kumánovics G, Varjú C, et al. Survival and causes of death in 366 Hungarian patients with systemic sclerosis. Ann Rheum Dis 2008;67:59-63.
25. Mannino DM, Etzel RA, Parrish RG. Pulmonary fibrosis deaths in the United States, 1979-1991. An analysis of multiple-cause mortality data. Am J Respir Crit Care Med 1996;153:1548-52.
26. Perera A, Fertig N, Lucas M, et al. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody. Arthritis Rheum 2007;56:2740-6.
27. Altman RD, Medsger TA Jr, Bloch DA, et al. Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum 1991;34:403-13.
28. Trad S, Amoura Z, Beigelman C, et al. Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease. Arthritis Rheum 2006;54:184-91.
29. Mathai SC, Hummers LK, Champion HC, et al. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease. Arthritis Rheum 2009;60:569-77.